{"result": {"id": "b68b9684-397b-43c0-ae2a-bb94470b3146", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>痛风性关节炎<|>EVENT<|>A condition characterized by recurrent arthritis attacks due to urate crystal deposition, requiring urate-lowering therapy when frequent\")  \n##  \n(\"entity\"<|>尿酸性肾石症<|>EVENT<|>A kidney stone condition caused by uric acid crystallization, considered an indication for urate-lowering therapy\")  \n##  \n(\"entity\"<|>高尿酸血症<|>EVENT<|>Elevated blood uric acid levels, which may progress to gout but often lacks symptoms\")  \n##  \n(\"entity\"<|>慢性肾脏病<|>EVENT<|>Chronic kidney disease (CKD) stages 3+, listed as a comorbidity influencing gout treatment decisions\")  \n##  \n(\"relationship\"<|>痛风性关节炎<|>痛风患者<|>Gout patients experience recurrent gouty arthritis attacks as a defining symptom<|>9\")  \n##  \n(\"relationship\"<|>尿酸性肾石症<|>痛风患者<|>Uric acid kidney stones are a potential complication of gout<|>7\")  \n##  \n(\"relationship\"<|>高尿酸血症<|>痛风患者<|>Asymptomatic hyperuricemia often precedes clinical gout<|>6\")  \n##  \n(\"relationship\"<|>慢性肾脏病<|>痛风患者<|>CKD is a common comorbidity affecting gout treatment strategies<|>8\")  \n##  \n(\"relationship\"<|>美国风湿病学会<|>痛风性关节炎<|>The ACR provides treatment guidelines for gouty arthritis management<|>8\")  \n##  \n(\"relationship\"<|>美国风湿病学会<|>高尿酸血症<|>The ACR issues conditional recommendations against treating asymptomatic hyperuricemia<|>6\")  \n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751559125, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 394, "prompt_tokens": 2743, "total_tokens": 3137, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 2688}, "prompt_cache_hit_tokens": 2688, "prompt_cache_miss_tokens": 55}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 中华内科杂志 2023 年 9 月第 62 卷第 9 期    Chin J Intern Med, September 2023, Vol. 62, No. 9\n\n\n　的饮料亦会导致血尿酸升高，应限制饮用 。无论疾  病活动与否，不推荐痛风患者补充维生素 C 制剂， 并且需强调的是，饮食控制不能代替降尿酸药物  治疗。\n（二）降尿酸药物治疗\n1. 降尿酸治疗的指征：痛风性关节炎发作≥\n　2 次；或痛风性关节炎发作 1 次且同时合并下述任  意一项：年龄<40 岁、血尿酸>480 μmol/L、有痛风石  或关节腔尿酸盐沉积证据、尿酸性肾石症或肾功能  损害［估算肾小球滤过率（eGFR）<90 ml/min］、高血  压、糖耐量异常或糖尿病、血脂紊乱、肥胖、冠心病、 卒中 、心功能不全 ；应立即开始降尿酸治疗［5?6］。 2020 年美国风湿病学会痛风管理指南对降尿酸治  疗的指征按照不同推荐强度提出了建议，强烈推  荐［7］：具有下述任意一种情况的痛风患者开始行降  尿酸治疗：皮下痛风石≥1 个，有证据表明存在痛风  引 起 的 任 何 影 像 学 损 害 ，或 痛 风 频 繁 发 作( ≥   2 次/年）；有条件推荐：对曾经发作>1 次，但发作不  频繁（<2 次/年）的痛风患者开始降尿酸治疗；对首  次出现痛风发作的患者，有条件反对起始降尿酸治  疗；对于首次痛风发作且合并中重度慢性肾脏病  （CKD）（CKD3 期及 3 期以上）、血尿酸>540 μmol/L   或尿路结石的患者，有条件推荐起始降尿酸治疗； 无症状高尿酸血症患者（血尿酸>420 μmol/L，无痛  风发作或皮下痛风石），有条件反对起始降尿酸  治疗。\n　　　2. 降尿酸治疗的时机：因血尿酸波动可导致痛 风急性发作，既往大多数痛风指南均不建议在痛风 急性发作期开始时使用降尿酸药物，须在抗炎、镇 痛治疗 2 周后再酌情使用 。亦有部分痛风指南提 出，在足量抗炎、镇痛药应用下，允许在痛风急性期 进行降尿酸治疗，但该建议的依据来自小样本的随 机对照研究，推荐级别弱，尚未被国内外学者普遍 接受 。如果在稳定的降尿酸治疗过程中出现痛风 急性发作，则无须停用降尿酸药物，可同时进行抗 炎、镇痛\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>中华内科杂志<|>ORGANIZATION<|>A medical journal publishing research and guidelines on internal medicine, including gout management\")  \n##  \n(\"entity\"<|>美国风湿病学会<|>ORGANIZATION<|>An organization that provides guidelines for gout management, including recommendations for urate-lowering therapy\")  \n##  \n(\"entity\"<|>痛风患者<|>PERSON<|>Individuals diagnosed with gout who may require urate-lowering therapy based on specific criteria\")  \n##  \n(\"entity\"<|>无症状高尿酸血症患者<|>PERSON<|>Individuals with elevated uric acid levels but no gout symptoms, for whom urate-lowering therapy is conditionally not recommended\")  \n##  \n(\"relationship\"<|>美国风湿病学会<|>中华内科杂志<|>The American College of Rheumatology's guidelines are referenced in the Chinese Journal of Internal Medicine for gout management<|>6\")  \n##  \n(\"relationship\"<|>痛风患者<|>美国风湿病学会<|>The American College of Rheumatology provides treatment recommendations for gout patients<|>7\")  \n##  \n(\"relationship\"<|>无症状高尿酸血症患者<|>美国风湿病学会<|>The American College of Rheumatology conditionally opposes urate-lowering therapy for asymptomatic hyperuricemia patients<|>5\")  \n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_3a0183576d39a9b579e07fb988466dbd324c316340690f12e17705f0b0178170_v2"}